CM
GBT

Caption Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Caption Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-162,000
Closed -$11M – 1887
2022
Q3 		$11M Buy
162,000
+102,000
+170% +$5.63M 0.15% 153
2022
Q2 		$1.92M Buy
60,000
+30,000
+100% +$878K 0.03% 679
2022
Q1 		$1.04M Buy
+30,000
New +$897K 0.01% 968
2021
Q3 		– Sell
-17,600
Closed -$618K – 1914
2021
Q2 		$618K Buy
+17,600
New +$687K 0.01% 998
2021
Q1 		– Sell
-100,000
Closed -$4.33M – 1491
2020
Q4 		$4.33M Buy
+100,000
New +$4.93M 0.1% 257
2020
Q3 		– Sell
-15,000
Closed -$946K – 1351
2020
Q2 		$946K Buy
+15,000
New +$1.03M 0.03% 543
2019
Q3 		– Sell
-100,000
Closed -$5.26M – 952
2019
Q2 		$5.26M Buy
100,000
+80,000
+400% +$4.6M 0.26% 109
2019
Q1 		$1.06M Buy
+20,000
New +$983K 0.06% 343

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's GBT Position: Q4 2022 in Review

Caption Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 18,900 shares — an estimated $1.29M sold.

Caption Management first reported a position in GBT in Q2 2018 and held it in 10 quarters. The position peaked at $7.18M in Q2 2021. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Caption Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Caption Management sold 18,900 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $1.29M.
  • Caption Management first reported a position in Global Blood Therapeutics, Inc. in Q2 2018 and held it in 10 quarters.
  • Caption Management's Global Blood Therapeutics, Inc. position peaked at $7.18M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.